MedTrace Logo

Improving Wisely - Polypharmacy

NCT03857100 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11000

Last updated 2021-02-23

No results posted yet for this study

Summary

This is a randomized controlled trial that uses an audit and feedback intervention to alert primary care physicians who are outliers in one or more metrics related to high risk prescribing of participants' outlier status. Primary care physicians will be randomized to the intervention or control arm, except in California, where all outliers will be notified. The investigators will evaluate the impact of the intervention on prescribing patterns.

Conditions

  • Adverse Drug Event

Interventions

OTHER

Audit and feedback - letter and report

letter describing project and report of participants' outlier status and how participants compare to peers

Sponsors & Collaborators

Principal Investigators

  • Martin A Makary, MD, MPH · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-04
Primary Completion
2021-01-30
Completion
2021-01-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03857100 on ClinicalTrials.gov